NOACs Use in AF or VTE (SUNSHINE Registry)

Launched by HENAN PROVINCIAL PEOPLE'S HOSPITAL · May 12, 2022

Keywords

ClinConnect Summary

The SUNSHINE Registry is a clinical trial that aims to understand how well new types of blood thinners, called non-vitamin K antagonist oral anticoagulants (NOACs), work for patients with two specific conditions: atrial fibrillation (AF) and venous thromboembolism (VTE). This study gathers real-world data from hospitals and clinics to see how these medications are used and what outcomes patients experience. By looking at a large group of patients, the trial hopes to provide valuable insights into the safety and effectiveness of NOACs in everyday healthcare settings.

To be eligible for this study, patients must have a diagnosis of AF or VTE and have been using blood thinners within the last three months. The trial is open to individuals of all ages and genders, and patients can be enrolled whether they are in the hospital or visiting a clinic. Participants will be asked to share their medical information, which will help researchers analyze the benefits and risks of NOACs in a broader patient population. It’s important to note that certain patients, such as those with specific heart conditions or who are currently involved in other clinical trials, may not qualify for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with clinically diagnosed with AF (eg, by electrocardiogram, Holter monitoring, implanted device, etc) or VTE (initial or recurrent acute VTE)
• • Patients who use OACs therapy (including NOAC or VKA) within the preceding 3 months
• • Patients can be enrolled from both inpatient or outpatient settings
• Exclusion Criteria:
• • AF resulting from reversible cause factors (e.g., thyroid disease, postoperative AF)
• • Patients with a diagnosis of valvular AF (valvular AF mainly refers to patients with AF that have either rheumatic valvular disease \[predominantly mitral stenosis\] or mechanical heart valves)
• • Patients participating in an ongoing clinical trial in AF or VTE
• • Have Multiple anticoagulation indications apart from AF or VTE
• • Patients with incomplete information (illogical data, missing or insufficient data)